Literature DB >> 20699774

Development of a challenge assessment tool for high-functioning children with an acquired brain injury.

Robyn J Ibey1, Rochelle Chung, Nicole Benjamin, Shannon Littlejohn, Andrea Sarginson, Nancy Margaret Salbach, Gail Kirkwood, Virginia Wright.   

Abstract

PURPOSE: To develop a performance-based challenge assessment to evaluate gross motor abilities of high-functioning youth with an acquired brain injury (ABI).
METHODS: Potential items were identified from the literature. A panel of 4 expert physical therapists selected items on the basis of 3 criteria: safety to test, feasibility to administer, and importance to perform. Item reduction was completed using ratings from a physical therapist web survey. The Acquired Brain Injury-Challenge Assessment (ABI-CA) was created and pilot tested with youth with an ABI.
RESULTS: Seventy-eight items were identified and reduced to 47 items following expert panel discussion. Web-survey item reduction by 75 pediatric physical therapists yielded a 24-item ABI-CA that was administered to 6 youth with an ABI, aged 8 to 17 years. The ABI-CA mean score was 50.7/81.0 (SD = 17.4).
CONCLUSION: The ABI-CA was feasible to administer and demonstrated gross motor activity challenges beyond the Gross Motor Function Measure. Response option refinement and measure validation are required prior to clinical/research use.

Entities:  

Mesh:

Year:  2010        PMID: 20699774     DOI: 10.1097/PEP.0b013e3181ea8ff6

Source DB:  PubMed          Journal:  Pediatr Phys Ther        ISSN: 0898-5669            Impact factor:   3.049


  2 in total

1.  Dissemination of student research in a canadian master of science in physical therapy programme.

Authors:  Nancy M Salbach; Kelly O'Brien; Cathy Evans; Karen Yoshida
Journal:  Physiother Can       Date:  2013       Impact factor: 1.037

2.  Further Development of the Assessment of Military Multitasking Performance: Iterative Reliability Testing.

Authors:  Margaret M Weightman; Karen L McCulloch; Mary V Radomski; Marsha Finkelstein; Amy S Cecchini; Leslie F Davidson; Kristin J Heaton; Laurel B Smith; Matthew R Scherer
Journal:  PLoS One       Date:  2017-01-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.